Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogen (NEOG) Asset Writedowns and Impairment (2023 - 2025)

Neogen (NEOG) has 3 years of Asset Writedowns and Impairment data on record, last reported at -$470.8 million in Q2 2025.

  • For Q2 2025, Asset Writedowns and Impairment fell 84782.01% year-over-year to -$470.8 million; the TTM value through May 2025 reached -$468.9 million, down 18962.48%, while the annual FY2024 figure was $556000.0, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached -$470.8 million in Q2 2025 per NEOG's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $2.1 million in Q1 2025 and bottomed at -$470.8 million in Q2 2025.
  • Average Asset Writedowns and Impairment over 3 years is -$94.2 million, with a median of -$716000.0 recorded in 2024.
  • The widest YoY moves for Asset Writedowns and Impairment: up 387.01% in 2025, down 84782.01% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at -$2.3 million in 2023, then soared by 124.17% to $556000.0 in 2024, then plummeted by 84782.01% to -$470.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Writedowns and Impairment were -$470.8 million in Q2 2025, $2.1 million in Q1 2025, and $556000.0 in Q2 2024.